1 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Histidine: new trials by email Literature Review of Histidine trials Research Report on Histidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Histaminergic Basis of Fatigue in Multiple Sclerosis L-Histidine, Placebo, Lodosyn - Multiple Sclerosis | Phase 2 | Withdrawn | University of Miami | 2022-01-01 | 2021-07-29 | |
| Histidine Therapy: A Project to Treat HARS Deficiency L-Histidine - HARS Syndrome | Phase 2 / Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 14 | 2018-08-01 | 2022-06-10 |
| Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer Seribantumab, Fulvestrant, Placebo - Metastatic Breast Cancer | Phase 2 | Terminated | Elevation Oncology | 22 | 2017-08-15 | 2020-09-02 |
| Neurovascular Transduction During Exercise in Chronic Kidney Disease 6R-BH4, 6R-BH4 placebo, Folic acid - Renal Insufficiency, Chronic | Phase 2 | Recruiting | Emory University | 150 | 2016-10-01 | 2026-05-18 |
| Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults Essential Amino Acids (EAA), Placebo (Alanine) - Muscle Atrophy, Quality of Life | Phase 2 | Completed | University of Oregon | 80 | 2014-12-01 | 2024-07-23 |
Breast Neoplasms (1) · Fatigue (1) · Hypertension (1) · Kidney Diseases (1) · Multiple Sclerosis (1) · Muscular Atrophy (1) · Renal Insufficiency, Chronic (1)
Elevation Oncology (1) · Emory University (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · University of Miami (1) · University of Oregon (1)
United States (4) · Canada (2) · Austria (1) · Belgium (1) · Germany (1) · Spain (1)
Joe Nocera, PhD (1) · Kottil Rammohan, MD (1) · Marc Pipas, MD (1)
PMID 26733251, PMID 26829246, PMID 30280129, PMID 31343947, PMID 36810250
2017 (1), R01AG046401 (1), R01HL135183 (1)